(Q40769238)

23 September 2017

0 references

Pertussis: acellular, whole-cell, new vaccines, what to choose? (English)

1 reference

23 September 2017

1

Camille Locht

1 reference

23 September 2017

language of work or name

1 reference

3 March 2016

1 reference

Expert Review of Vaccines

23 September 2017

published in

1 reference

23 September 2017

volume

15

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

671-673

1 reference

Clinical practice. Pertussis--not just for kids

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Systematic review of the effects of pertussis vaccines in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Asymptomatic transmission and the resurgence of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Estimating the duration of pertussis immunity using epidemiological signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Live attenuated vaccines against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Effectiveness of maternal pertussis vaccination in England: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

Reciprocal interference of maternal and infant immunization in protection against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1161511

10.1586/14760584.2016.1161511

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference